What, Why & How

For the final episode of 2023, IPA’s Seth Brown welcomes Michael Baxter, Vice President of Federal Government Affairs at the American Pharmacists Association (APhA), to discuss direct and indirect remuneration (DIR) fees and the Medicare Part D Final Rule going into effect January 1, 2024.

Following the August 29 Iowa Board of Pharmacy meeting, IPA’s Seth Brown welcomes Sue Mears from the Board of Pharmacy to discuss Iowa's state government realignment and what it means for the Board of Pharmacy.

Following the May 2 Iowa Board of Pharmacy meeting, IPA’s Seth Brown welcomes Sue Mears from the Board of Pharmacy to discuss Executive Agency rulemaking and Executive Order #10.

Following the February 28 Iowa Board of Pharmacy meeting, IPA staff welcomes special guest Mitch Barnett, Associate Director of the Prescription Monitoring Program (PMP) at the Board of Pharmacy, to discuss the Board’s Disposal Kit Dispensing Program.

Following the January 10 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss IPA’s 2023 Legislative Priorities, the Board’s rulemaking related to the Iowa Prescription Monitoring Program (PMP), and more.

On December 5, IPA’s Director of Public Affairs, Seth Brown, and Senior Policy Advisor, Brett Barker, recorded a special podcast episode on the Iowa Insurance Division’s release of the PBM rules following the passage of the PBM bill last session. No CE available.

Following the October 25 Iowa Board of Pharmacy meeting, IPA staff and Andrew Funk from the Board of Pharmacy discuss the role of the Board and programs offered, updated USP compounding standards, and delegation of technical functions to nurses.

Following the August 24 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the rulemaking process and how a rule is adopted, as well as the Board’s newly adopted compounding rule. In addition, Becky Carlson speaks on the IMP3 Program and its importance in Iowa.

Following the June 28 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the Board’s updated security and controlled substance accountability rules, as well as changes to the Statewide Protocols for naloxone, immunization and tobacco cessation.

Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.

Following the March 1 Iowa Board of Pharmacy meeting, IPA’s Vice President of Government Affairs, Brett Barker, and Sue Mears from the Board of Pharmacy discuss the Board’s 2022 legislation regarding controlled substances and the authority of nurses practicing under a pharmacist’s order, as well as recent rulemaking and telepharmacy provisions from the Board.

Following the January 11 Iowa Board of Pharmacy meeting, IPA’s Government Relations team, Damian Thompson and Brett Barker, and Sue Mears from the Board of Pharmacy discuss federal comment periods for USP revisions, the DEA rulemaking regarding telepharmacy and transfer of electronic prescriptions for controlled substances, as well as recent rulemaking from the Board.

Following the November 10 Iowa Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss rule changes impacting telepharmacy, technicians, and potential legislation in the 2022 session.

Following the August 31 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss the recently noticed collaborative practice rules and board approved test and treat protocols.